Business
With the Moderna share price blasting up, have the forward-looking markets got it right?
The Moderna Inc (NASDAQ: MRNA) share price went like gangbusters yesterday, overnight Aussie time. The US biotech company’s share price leapt 10.8%. And its up another 3.8% in afterhours trading.
This comes as investors eagerly anticipate the outcome of the final analysis of Moderna’s promising COVID-19 vaccine trial.
Earlier this month, Moderna joined Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) in a globally exclusive club when the company announced its vaccine looked to be 95% effective in its extensive trial. One which encompassed 30,000 people.
Moderna’s share price is now up 62% so far in November, and 468% so far in 2020. At the current share price, Moderna has a market cap of $48 billion.
What does Moderna…
-
Noosa News15 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News13 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
General18 hours agoOne person dead after house fire in Melbourne’s south-east
-
Business11 hours agoHow these 5 ASX 200 stocks are smashing the benchmark this week